Bristol Myers Squibb (BMY)

Investing Cash Flow

-$1.61B

Quarterly · Period ending: · USD

BMY logo

BMY Investing Cash Flow

Latest reported-$1.61B
BMY Quarterly Cash from Investing ($352.00M → -$1.61B)
High-resolution chart · PNG

BMY investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-1,614,000,000
-131,000,000
-1,458,000,000
-1,702,000,000
-473,000,000
-499,000,000
-196,000,000
-219,000,000
-1,319,000,000
-19,618,000,000
-1,346,000,000
-410,000,000
-329,000,000
-210,000,000
1,213,000,000
-2,081,000,000
-289,000,000
95,000,000
401,000,000
-976,000,000
180,000,000
-143,000,000
-12,127,000,000
-213,000,000
556,000,000
610,000,000
-12,036,000,000
491,000,000
715,000,000
1,060,000,000
-336,000,000
-147,000,000
-348,000,000
-43,000,000
1,019,000,000
142,000,000
-1,024,000,000
-203,000,000
16,000,000
-368,000,000
406,000,000
1,426,000,000
-984,000,000
-62,000,000
-1,280,000,000
754,000,000
351,000,000
164,000,000
-1,511,000,000
2,212,000,000
-315,000,000
-475,000,000
57,000,000
161,000,000
277,000,000
-4,203,000,000
226,000,000
-3,027,000,000
495,000,000
-163,000,000
-332,000,000
-1,437,000,000
-2,479,000,000
948,000,000
238,000,000
-2,519,000,000
-1,027,000,000
-1,989,000,000
-438,000,000
-926,000,000
1,074,000,000
3,910,000,000
-481,000,000
576,000,000
34,000,000
394,000,000
-637,000,000
7,000,000
740,000,000
-112,000,000
-145,000,000
-277,000,000
-1,323,000,000
82,000,000
1,503,000,000
929,000,000
-113,000,000
-480,000,000
-426,000,000
-603,000,000
-1,649,000,000
-521,000,000
-294,000,000
-620,000,000
-328,000,000
-326,000,000
-129,000,000
-589,000,000
3,071,000,000
-7,514,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.